BCYC
Price
$14.95
Change
-$0.04 (-0.27%)
Updated
Dec 4, 6:59 PM EST
84 days until earnings call
SAGE
Price
$20.84
Change
+$0.45 (+2.21%)
Updated
Dec 4, 6:59 PM EST
79 days until earnings call
Ad is loading...

Analysis and predictions BCYC vs SAGE

Header iconBCYC vs SAGE Comparison
Open Charts BCYC vs SAGEBanner chart's image
Bicycle Therapeutics
Price$14.95
Change-$0.04 (-0.27%)
Volume$205.15K
CapitalizationN/A
Sage Therapeutics
Price$20.84
Change+$0.45 (+2.21%)
Volume$328.35K
CapitalizationN/A
View a ticker or compare two or three
BCYC vs SAGE Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
BCYC vs. SAGE commentary
Dec 05, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Buy and SAGE is a Buy.

COMPARISON
Comparison
Dec 05, 2023
Stock price -- (BCYC: $14.95 vs. SAGE: $20.84)
Brand notoriety: BCYC and SAGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 96% vs. SAGE: 77%
Market capitalization -- BCYC: $525M vs. SAGE: $1.15B
BCYC [@Biotechnology] is valued at $525M. SAGE’s [@Biotechnology] market capitalization is $1.15B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileSAGE’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • SAGE’s FA Score: 0 green, 5 red.
According to our system of comparison, BCYC is a better buy in the long-term than SAGE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 5 TA indicator(s) are bullish while SAGE’s TA Score has 5 bullish TA indicator(s).

  • BCYC’s TA Score: 5 bullish, 3 bearish.
  • SAGE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than SAGE.

Price Growth

BCYC (@Biotechnology) experienced а +7.40% price change this week, while SAGE (@Biotechnology) price change was +9.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.40%. For the same industry, the average monthly price growth was +26.79%, and the average quarterly price growth was +25.75%.

Reported Earning Dates

BCYC is expected to report earnings on Feb 27, 2024.

SAGE is expected to report earnings on Feb 22, 2024.

Industries' Descriptions

@Biotechnology (+5.40% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BCYC with price predictions.
OPEN
A.I.dvisor published
a Summary for SAGE with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SAGE($1.15B) has a higher market cap than BCYC($525M). SAGE YTD gains are higher at: -45.359 vs. BCYC (-49.493). BCYC has higher annual earnings (EBITDA): -151.28M vs. SAGE (-656.8M). SAGE has more cash in the bank: 876M vs. BCYC (572M). SAGE has less debt than BCYC: SAGE (6.97M) vs BCYC (45.7M). BCYC has higher revenues than SAGE: BCYC (24.8M) vs SAGE (11.3M).
BCYCSAGEBCYC / SAGE
Capitalization525M1.15B46%
EBITDA-151.28M-656.8M23%
Gain YTD-49.493-45.359109%
P/E RatioN/A2.85-
Revenue24.8M11.3M219%
Total Cash572M876M65%
Total Debt45.7M6.97M656%
FUNDAMENTALS RATINGS
SAGE: Fundamental Ratings
SAGE
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
10

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCSAGE
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
69%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 1 day ago
74%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 20 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
79%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WQDGX9.750.03
+0.31%
WCM Quality Dividend Growth Investor
DYGAX13.17N/A
N/A
Meeder Dynamic Allocation Adviser
MMLRX13.16N/A
N/A
MassMutual Select TRP Large Cap Blend I
PEQYX14.77-0.06
-0.40%
Putnam Focused International Equity Y
DFETX17.19-0.10
-0.58%
DFA Emerging Markets II

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with PHIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-0.27%
PHIO - BCYC
41%
Loosely correlated
+1.36%
DYN - BCYC
41%
Loosely correlated
+4.29%
MLTX - BCYC
39%
Loosely correlated
+2.58%
STRO - BCYC
36%
Loosely correlated
+4.36%
DNLI - BCYC
35%
Loosely correlated
-1.00%
More